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CONCLUSION 
  
Dexmedetomidine-induced fever is a rare side effect that clinicians should be 
aware of, especially in the ICU setting, where it is a common choice for 
sedation. Since there are so few documented cases and the fever can 
manifest at varying time intervals2, dexmedetomidine fever should be 
considered in the differential diagnosis for fever for any patient receiving it for 
sedation.  One possible explanation for the mechanism of fever is via direct 
stimulation of areas of the brain responsible for thermoregulation, such as the 
Caudal Raphe Magnus by the Locus Coeruleus.1  The Locus Coeruleus, as  
the primary site of action of Dexmedetomidine, is implicated in many 
important physiologic functions, although why some patients develop fever 
and others do not is not understood.2  Diagnosis of dexmedetomidine-
induced drug fever should be treated immediately, since body temperature 
can become severely elevated.  As with other cases of drug fever, the 
offending agent should be discontinued and active cooling measures  
initiated.  IV acetaminophen and cooling blankets can be employed and other 
causes of fever must be considered since dexmedetomidine-induced fever is 
a diagnosis of exclusion.  
INTRODUCTION 
 
I am pleased to present a case highlighting a rare complication of dexmedetomidine and 
describing: (1). Its relationship to the administration of dexmedetomidine; (2). A possible 
mechanism for dexmedetomidine-induced fever; and (3). Management of 
dexmedetomidine-induced fever in a critical care setting.  
 
 
CASE HISTORY 
 
A 79-year-old male with incarcerated umbilical hernia, afebrile and on broad spectrum 
antibiotics, underwent a right hemicolectomy for incarcerated inguinal hernia. Following 
uneventful surgery, the patient was transferred to ICU for postoperative management.  
Intravenous dexmedetomidine infusion (1mg/kg bolus followed by 0.4 mcg/kg/hr) was 
started for postoperative agitation.  However, shortly after starting the infusion, the patient 
became febrile to 105.8° by esophageal temperature.  Dexmedetomidine infusion was 
discontinued, one (1) gram of intravenous acetaminophen was given, and a cooling blanket 
was applied;  the fever subsequently decreased with complete resolution to normal baseline 
at six hours. 
 
  
 
 
DISCUSSION 
 
Dexmedetomidine’s primary site of action is the Locus Coeruleus,  the major 
noradrenergic nucleus of the brain that communicates with a wide subset of neural 
structures and plays a central role in a number of physiologic functions.1  The primary 
effect of dexmedetomidine on the Locus Coeruleus is regulation of arousal, making it a 
common choice for sedation in the ICU.  Recently, however, it has been found to play a 
role in the control of autonomic function1 with the rare side effect of pyrexia.  Nuclei in the 
Caudal Raphe Magnus are involved in thermoregulation, causing increases in body 
temperature secondary to direct stimulation from the Locus Coeruleus.1  
Dexmedetomidine has been implicated in a small but growing number of case reports of 
drug-induced fever as a rare side effect.2  In our case, after starting dexmedetomidine 
according to our institutional standards and established critical care guidelines3, an 
extreme fever was noted;  dexmedetomidine was immediately suspect due to the timing of 
the fever and lack of other readily identifiable causes, therefore it was immediately 
discontinued and the fever treated.  
 
